CARBIDOPA AND LEVORDOPA TABLETS, USP 25MG/100MG 100 TABLETS; NDC/UPC 51862-856-01; RX; TABLETS
Recall Number: D-0520-2021
Firm: Cardinal Health Inc.
Classification: Class II
Status: Terminated
Report Date: 20210602
Initiation Date: 20210315
Termination Date: 20240617
Reason for Recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Product Description
CARBIDOPA AND LEVORDOPA TABLETS, USP 25MG/100MG 100 TABLETS; NDC/UPC 51862-856-01; RX; TABLETS